Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunoprecise Antibodies Ltd

0.3849
-0.0201-4.96%
Post-market: 0.3600-0.0249-6.47%19:59 EDT
Volume:1.85M
Turnover:711.10K
Market Cap:17.61M
PE:-0.52
High:0.4050
Open:0.3959
Low:0.3602
Close:0.4050
Loading ...

ImmunoPrecise Antibodies Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Mar

Human rights groups challenge Apple’s privacy fight with the UK government

cityam
·
14 Mar

Sector Update: Health Care Stocks Softer Thursday Afternoon

MT Newswires Live
·
14 Mar

Sector Update: Health Care Stocks Flat to Lower Premarket Thursday

MT Newswires Live
·
13 Mar

Positive Signs As Multiple Insiders Buy ImmunoPrecise Antibodies Stock

Simply Wall St.
·
13 Mar

ImmunoPrecise Antibodies Signs Partnership Deal to Develop Cancer Treatments

MT Newswires Live
·
13 Mar

ImmunoPrecise in $8M deal with biotech firm for ADCs in cancer treatments

TIPRANKS
·
13 Mar

IPA to Reschedule Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 28, 2025

Business Wire
·
12 Mar

From Challenge to Change: New ABB and Fraunhofer IPA Report on How Hard-to-Abate Industries Can Achieve Net Zero

Business Wire
·
11 Mar

Marcus & Millichap’s IPA Capital Markets Arranges $61M Redevelopment Financing in Huntington Beach

Business Wire
·
07 Mar

IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 13, 2025

Business Wire
·
05 Mar

IPA and RIBOPRO Partner to Advance mRNA-Driven Antibody Discovery, Unlocking New Frontiers in Immunotherapy

Business Wire
·
26 Feb

Press Release: Goodman Real Estate Announces Acquisition of Town Deer Valley Apartments in Phoenix, Arizona

Dow Jones
·
25 Feb

Immunoprecise Antibodies Ltd - Appoints Kamil Isaev to Board and Joseph Scheffler as Interim CFO

THOMSON REUTERS
·
24 Feb

Immunoprecise Antibodies Announces Key Leadership Changes

THOMSON REUTERS
·
24 Feb

ImmunoPrecise Antibodies Announces Key Leadership Changes

Business Wire
·
24 Feb